HYPERLIPASAEMIA

HYPERLIPASAEMIA was reported 524 times

HYPERLIPASAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 7 0.0012
1 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
2 Cannabinoid [EPC] 6 0.0007
3 Sphingosine 1-phosphate Receptor Modulator [EPC] 7 0.0005
4 Programmed Death Ligand-1 Blocker [EPC] 10 0.0005
5 Gonadotropin [EPC] 1 0.0005
6 Lipid Emulsion [EPC] 1 0.0004
7 Asparagine-specific Enzyme [EPC] 5 0.0004
8 Programmed Death Receptor-1 Blocking Antibody [EPC] 33 0.0003
9 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 22 0.0002
10 Glinide [EPC] 2 0.0002
11 Protease Inhibitor [EPC] 9 0.0002
12 Dipeptidyl Peptidase 4 Inhibitor [EPC] 6 0.0002
13 Penem Antibacterial [EPC] 6 0.0002
14 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 19 0.0002
15 Non-Standardized Insect Allergenic Extract [EPC] 1 0.0002
16 Cytochrome P450 3A Inhibitor [EPC] 10 0.0002
17 Bile Acid Sequestrant [EPC] 2 0.0002
18 Platinum-based Drug [EPC] 41 0.0001
19 GLP-2 Analog [EPC] 2 0.0001
20 Histamine-1 Receptor Antagonist [EPC] 12 0.0001
21 Standardized Insect Venom Allergenic Extract [EPC] 1 0.0001
22 Provitamin D2 Compound [EPC] 4 0.0001
23 Topoisomerase Inhibitor [EPC] 10 0.0001
24 CTLA-4-directed Blocking Antibody [EPC] 6 0.0001
25 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
26 Nuclear Export Inhibitor [EPC] 1 0.0001
27 GLP-1 Receptor Agonist [EPC] 51 0.0001
28 Thiazide Diuretic [EPC] 23 0.0001
29 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 11 0.0001
30 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
31 Serotonin-3 Receptor Antagonist [EPC] 13 0.0001
32 Antimalarial [EPC] 1 0.0001
33 Angiotensin Converting Enzyme Inhibitor [EPC] 13 0.0001
34 Antiprotozoal [EPC] 1 0.0001
35 Antimetabolite Immunosuppressant [EPC] 2 0.0001
36 Sulfone [EPC] 1 0.0001
37 General Anesthetic [EPC] 4 0.0001
38 Antimycobacterial [EPC] 2 0.0001
39 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0001
40 Angiotensin 2 Receptor Blocker [EPC] 26 0.0001
41 Nucleoside Metabolic Inhibitor [EPC] 22 0.0001
42 Proteasome Inhibitor [EPC] 9 0.0001
43 PCSK9 Inhibitor [EPC] 2 0.0001
44 Aldosterone Antagonist [EPC] 12 0.0001
45 Glycopeptide Antibacterial [EPC] 5 0.0001
46 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
47 Purine Antimetabolite [EPC] 7 0.0001
48 Peroxisome Proliferator Receptor alpha Agonist [EPC] 4 0.0001
49 Proton Pump Inhibitor [EPC] 40 0.0001
50 Potassium Binder [EPC] 1 0.0001
51 Mood Stabilizer [EPC] 14 0.0001
52 Prostaglandin E1 Analog [EPC] 1 0.0001
53 HMG-CoA Reductase Inhibitor [EPC] 22 0.0001
54 Anti-epileptic Agent [EPC] 13 0.0001
55 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
56 Cholinesterase Inhibitor [EPC] 1 0.0001
57 Sulfonylurea [EPC] 6 0.0000
58 Microtubule Inhibitor [EPC] 8 0.0000
59 Fluoroquinolone Antibacterial [EPC] 6 0.0000
60 Amide Local Anesthetic [EPC] 4 0.0000
61 Nitroimidazole Antimicrobial [EPC] 3 0.0000
62 Alkylating Drug [EPC] 11 0.0000
63 Azole Antifungal [EPC] 7 0.0000
64 Dietary Cholesterol Absorption Inhibitor [EPC] 4 0.0000
65 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
66 Aluminum Complex [EPC] 1 0.0000
67 Nonsteroidal Anti-inflammatory Drug [EPC] 54 0.0000
68 Opioid Agonist [EPC] 11 0.0000
69 Antiarrhythmic [EPC] 4 0.0000
70 RANK Ligand Inhibitor [EPC] 8 0.0000
71 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
72 Histamine-2 Receptor Antagonist [EPC] 5 0.0000
73 Alkaloid [EPC] 1 0.0000
74 Androgen [EPC] 1 0.0000
75 Catecholamine [EPC] 3 0.0000
76 Folate Analog Metabolic Inhibitor [EPC] 16 0.0000
77 Nucleoside Analog Antiviral [EPC] 3 0.0000
78 gamma-Aminobutyric Acid-ergic Agonist [EPC] 3 0.0000
79 Oxazolidinone Antibacterial [EPC] 1 0.0000
80 BCL-2 Inhibitor [EPC] 2 0.0000
81 Loop Diuretic [EPC] 14 0.0000
82 beta-Adrenergic Blocker [EPC] 9 0.0000
83 Insulin Analog [EPC] 13 0.0000
84 Xanthine Oxidase Inhibitor [EPC] 5 0.0000
85 Platelet Aggregation Inhibitor [EPC] 16 0.0000
86 Benzodiazepine [EPC] 19 0.0000
87 Rifamycin Antibacterial [EPC] 1 0.0000
88 Osmotic Laxative [EPC] 8 0.0000
89 Kinase Inhibitor [EPC] 15 0.0000
90 Vitamin B12 [EPC] 8 0.0000
91 Phosphodiesterase 4 Inhibitor [EPC] 4 0.0000
92 Atypical Antipsychotic [EPC] 11 0.0000
93 Vitamin D [EPC] 7 0.0000
94 Nitrate Vasodilator [EPC] 2 0.0000
95 Aminoglycoside Antibacterial [EPC] 1 0.0000
96 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
97 Muscle Relaxant [EPC] 1 0.0000
98 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
99 Copper-containing Intrauterine Device [EPC] 1 0.0000
100 5-alpha Reductase Inhibitor [EPC] 2 0.0000
101 Vitamin C [EPC] 8 0.0000
102 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
103 Macrolide Antimicrobial [EPC] 1 0.0000
104 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
105 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
106 Methylxanthine [EPC] 1 0.0000
107 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
108 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
109 Vascular Endothelial Growth Factor Inhibitor [EPC] 3 0.0000
110 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
111 alpha-Adrenergic Blocker [EPC] 2 0.0000
112 Corticosteroid [EPC] 18 0.0000
113 Thalidomide Analog [EPC] 7 0.0000
114 HER2/neu Receptor Antagonist [EPC] 1 0.0000
115 Non-Standardized Chemical Allergen [EPC] 1 0.0000
116 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
117 Integrin Receptor Antagonist [EPC] 1 0.0000
118 Central Nervous System Stimulant [EPC] 1 0.0000
119 Factor Xa Inhibitor [EPC] 3 0.0000
120 Prostaglandin Analog [EPC] 1 0.0000
121 Aminosalicylate [EPC] 1 0.0000
122 Interleukin-12 Antagonist [EPC] 1 0.0000
123 Interleukin-23 Antagonist [EPC] 1 0.0000
124 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
125 Calcium [EPC] 1 0.0000
126 Janus Kinase Inhibitor [EPC] 1 0.0000
127 Retinoid [EPC] 1 0.0000
128 Tumor Necrosis Factor Blocker [EPC] 3 0.0000